81% in COVID-19 Vaccine Trial With Human Fetal Cell Line Suffer Adverse Reactions

A Chinese COVID-19 vaccine clinical trial is reporting early results that show 81% of the participants suffered at least one adverse reaction within seven days after vaccination. The trial, developed by CanSino Biologics, uses cell lines from an aborted human fetus, along with a chimpanzee adenovirus vector. Canada’s National Research Council is also using the human cell line for its COVID-19 vaccine candidates. Adverse reactions reported so far with CanSino’s vaccine range...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports